KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arbutus Biopharma (ABUS) Interest Coverage Ratio (2017 - 2025)

Arbutus Biopharma (ABUS) has disclosed Interest Coverage Ratio for 9 consecutive years, with 293.89 as the latest value for Q4 2025.

  • Quarterly Interest Coverage Ratio rose 36.72% to 293.89 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 393.4 through Dec 2025, up 29.38% year-over-year, with the annual reading at 393.4 for FY2025, 29.38% up from the prior year.
  • Interest Coverage Ratio hit 293.89 in Q4 2025 for Arbutus Biopharma, up from 376.48 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 53.14 in Q2 2025 to a low of 917.82 in Q1 2025.
  • Historically, Interest Coverage Ratio has averaged 261.04 across 5 years, with a median of 97.73 in 2023.
  • Biggest five-year swings in Interest Coverage Ratio: plummeted 1028.81% in 2023 and later skyrocketed 108.37% in 2025.
  • Year by year, Interest Coverage Ratio stood at 37.14 in 2021, then tumbled by 96.62% to 73.02 in 2022, then tumbled by 545.78% to 471.52 in 2023, then rose by 1.5% to 464.43 in 2024, then surged by 36.72% to 293.89 in 2025.
  • Business Quant data shows Interest Coverage Ratio for ABUS at 293.89 in Q4 2025, 376.48 in Q3 2025, and 53.14 in Q2 2025.